{"schema_version":"secwatch.filing_event.v1","accession":"0000719135-21-000068","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2021-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.591760+00:00","generated_at":"2026-06-29T07:08:21.845701+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Apyx Medical appoints Wendy Levine to Board of Directors","bullets":["Wendy Levine appointed as a director effective August 25, 2021, expanding the Board to eight members.","Levine will serve on the Regulatory Compliance Committee.","She is Group President and head of advertising at 21GRAMS, part of Real Chemistry, with 25 years of healthcare marketing experience.","Previous roles include leadership at Johnson & Johnson, Novartis Vaccines, McCann Health, and GSW.","No arrangement with any other person led to her election; compensation follows standard director program."],"urls":{"canonical":"https://secwatch.observer/filing/0000719135-21-000068","json":"https://secwatch.observer/filing/0000719135-21-000068.json","markdown":"https://secwatch.observer/filing/0000719135-21-000068.md","text":"https://secwatch.observer/filing/0000719135-21-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000071913521000068/0000719135-21-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000071913521000068/a8-kforwendy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T07:08:21.845701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b94d990b07","claim":"Wendy Levine was appointed as Director at Apyx Medical Corp.","evidence_excerpt":"On August 24, 2021, the Board of Direct ors (the “Board”) of Apyx Medical Corporation (the “Company”) appointed Wendy Levine to serve as a director of the Company, expanding its Board to eight (8) directors, effective August 25, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000071913521000068/0000719135-21-000068-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}